Venous Leg Ulcer
150
27
33
63
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
26 trials with published results (17%)
Research Maturity
63 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.0%
15 terminated out of 150 trials
80.8%
-5.8% vs benchmark
9%
14 trials in Phase 3/4
41%
26 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 63 completed trials
Clinical Trials (150)
Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
PMCF Study of Debridement Pad
Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers
A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Feasibility and Tolerance Study for the Treatment of Varicose Ulcers by Cyanoacrylate Glue (ETUVVE)
LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
COMS for Chronic Ulcers Treatment
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
PAW-Hydrogel for Chronic Wound Healing
Diagnostics in the Leg Ulcer Pathway
Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers